NeuroPace NPCE
NASDAQ NPCE
$13.64 -0.12 (-0.87%)
As of: Oct 1, 2026 · 9:47 AM EDT

NeuroPace (NPCE) Preferred Stock Liabilities (2020 - 2021)

Updated

NeuroPace's Preferred Stock Liabilities was $141.42 million in Q1 2021, up 92.2% from $73.57 million a year earlier and unchanged from the prior quarter.

Analysis

NeuroPace (NPCE) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

From Q1 2020 onward, NeuroPace has reported Preferred Stock Liabilities for 5 quarters.

  • Per Business Quant data, NPCE's Preferred Stock Liabilities in the three quarters before Q1 2021 was $141.42 million (Q4 2020), $141.42 million (Q3 2020) and $73.45 million (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 NeuroPace 471.73 Mn 244.98 Mn 18.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 141.42 Mn
Dec 31, 2020 141.42 Mn
Sep 30, 2020 141.42 Mn
Jun 30, 2020 73.45 Mn
Mar 31, 2020 73.57 Mn
API Access

NeuroPace Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NPCE&period=max&api_key=YOUR_API_KEY